Anthony Palmieri

Advisor at Erivan Bio

Dr. Palmieri retired from the faculty at the University of Florida College of Pharmacy in the Department of Pharmaceutics. He has authored of over 80 publications and presentations on pharmaceutics, intellectual property, dosage forms, dissolution, pharmacy education and the history of pharmacy. He has interacted extensively with USAN and WHO to obtain non-proprietary names for Pharmacia and Upjohn. Dr. Palmieri is Past Chairman of the USAN Council, and he is presently on the USAN review board. He has consulted as an expert witness on numerous litigations involving dose forms, excipients, bioequivalence, and dissolution. He is also an expert witness before the Office of Generic Drugs.

Dr. Palmieri has over twenty-five years of extensive and progressive responsibilities in an intellectual property management and technology transfer position, coupled with over fifteen years as a Professor of Pharmaceutics at major universities. Dr. Palmieri has successfully led projects across management lines where reporting relationships were often difficult to establish, no precedent existed, and the use of creative problem solving and communication skills were necessary.


Org chart

This person is not in the org chart


Teams

This person is not in any teams


Offices

This person is not in any offices


Erivan Bio

EriVan Bio is a biotechnology company, established to innovate and deliver products and services related to exosome technology for molecular and cell biology research and therapeutic purposes, particularly regenerative medicine and cancer treatment. EriVan Bio is focused on the development of a broad pipeline of novel and targeted biomolecules to address different unmet medical needs.


Industries

Employees

1-10

Links